Cargando…
Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels
Current treatments of hepatitis B virus (HBV) are limited to Interferon-alpha or the nucleos(t)ide analogs antiviral therapies, and it is crucial to develop and define new antiviral drugs to cure HBV. In this study, we explored the anti-HBV effect of difluoromethylornithine (DFMO), an irreversibly i...
Autores principales: | Mao, Binli, Wang, Zhuo, Pi, Sidie, Long, Quanxin, Chen, Ke, Cui, Jing, Huang, Ailong, Hu, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176913/ https://www.ncbi.nlm.nih.gov/pubmed/32373551 http://dx.doi.org/10.3389/fcimb.2020.00158 |
Ejemplares similares
-
Peptidyl-prolyl cis/trans isomerase Pin1 interacts with hepatitis B virus core particle, but not with HBc protein, to promote HBV replication
por: Kwon, Hyeonjoong, et al.
Publicado: (2023) -
Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication
por: Li, Jia, et al.
Publicado: (2022) -
Inhibition of Hepatitis B Virus (HBV) replication and antigen expression by Brucea javanica (L.) Merr. oil emulsion
por: Qin, Bo, et al.
Publicado: (2023) -
Endoplasmic Reticulum-Shaping Atlastin Proteins Facilitate KSHV Replication
por: Long, Wen-ying, et al.
Publicado: (2022) -
A Traditional Chinese Medicine, Maoto, Suppresses Hepatitis B Virus Production
por: Rahman, Md. Arifur, et al.
Publicado: (2021)